Comparative efficacy of biologics in psoriasis: a review. - Wikidata - wikimedia - TriplyDB

Comparative efficacy of biologics in psoriasis: a review.

Comparative efficacy of biologics in psoriasis: a review.

http://www.wikidata.org/entity/Q38042475

about

Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab The pathophysiological role of dendritic cell subsets in psoriasis.Retinal upregulation of inflammatory and proangiogenic markers in a model of neonatal diabetic rats fed on a high-fat-diet.Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece.An evolution in switching therapy for psoriasis patients who fail to meet treatment goals.Systemic therapies for psoriasis: an evidence-based update.Apremilast for the treatment of psoriatic arthritis.Pharmacological therapy of spondyloarthritis.The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis.A Real-World Study to Assess the Effectiveness of Itolizumab in Patients with Chronic Plaque Psoriasis.Control of late cornified envelope genes relevant to psoriasis risk: upregulation by 1,25-dihydroxyvitamin D3 and plant-derived delphinidin.Psoriasis and psoriatic arthritis in African-American patients--the need to measure disease burden.Objective measurement of erythema in psoriasis using digital color photography with color calibration.Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis.FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents.The Goeckerman regimen for the treatment of moderate to severe psoriasis.Bioactive Dietary VDR Ligands Regulate Genes Encoding Biomarkers of Skin Repair That Are Associated with Risk for Psoriasis.Efficacy and safety of ustekinumab in adolescents.

P2860

Q33573621-7690951B-24C6-4079-BA61-2C1401EFAB6B Q34180103-01BEB894-40CF-4C9D-86F7-17911076B799 Q34669369-FEA00045-28BD-4B21-9A85-5058C2D414C3 Q34894016-DD10B0F9-3BB0-4D04-B101-D44873D04031 Q34944668-54873727-E831-4BFD-8C0D-908552DB4660 Q37295966-97E323B7-3941-48A0-ADEB-FC43BF1FEB39 Q38185297-976C4EB4-DAF0-4209-976C-324025F2CB4F Q38202205-3D321AF3-0F7A-476A-AAD5-905F94F5FE07 Q38527552-B95D74C1-B847-4D72-A40E-7EC6BD090E02 Q38612964-8BB26774-D8EB-4827-9DF8-512E67295AB6 Q38650265-BBA96337-6A34-4546-B009-B02DA65B5D54 Q39128243-6FA138BD-C886-43D8-927E-2494DD2EA5B5 Q40218228-A66FC388-FF9F-492D-976B-B5494BFD9711 Q40326400-5CC70357-7E74-4A7A-ABBA-4D7C4DD3F546 Q41684920-4976AE8A-9001-4A57-A17D-007F09D1A388 Q41919734-0D440D32-CD4B-4966-84F8-38D4B2BC73D0 Q42540506-8BA938E3-7631-4382-AFE1-CD0DC28BC209 Q48104675-38AC1649-213B-45DA-801F-A0EBE3B23D88 Q49500789-DC4DF23F-C5CA-4430-9A68-BF4C54BB5FF6

P2860

Comparative efficacy of biologics in psoriasis: a review.

http://www.wikidata.org/entity/Q38042475

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Comparative efficacy of biologics in psoriasis: a review.

@en

type

label

Comparative efficacy of biologics in psoriasis: a review.

@en

prefLabel

Comparative efficacy of biologics in psoriasis: a review.

@en

P1433

Q38042475-ED1BA5E6-D7F7-43E8-8717-450EF4D051B7

P1476

Q38042475-4DA174CD-2D68-4525-B67D-B7BA800CD077

P2093

Q38042475-2C8C166C-9F25-453E-ACA4-C5DCCABFAAE3

Q38042475-61B469FE-4074-496E-BA7F-C79538187E27

Q38042475-63C51974-E570-48F2-A623-592CA1D5558E

Q38042475-6B24BA1C-39AF-4764-9253-21A7765B25EC

P2860

Q38042475-00B7B49E-46A6-497D-8931-12A53D22B017

Q38042475-0B9C78C6-1EDC-41E6-B32A-57F6272CC326

Q38042475-0BBD6AB5-EB88-40A3-A32D-20DB8BC66176

Q38042475-28D6ECA4-B06A-4139-89BD-DC5FFCED2D85

Q38042475-3FC3BB34-1622-427D-8770-DCB825A02F34

Q38042475-4680C079-9C78-4FFC-8F26-F5CB80184E19

Q38042475-7B90FEF9-16B0-40D9-81D8-CBB64E061903

Q38042475-80501613-9E51-4CC8-A2C6-6307BFAFBC96

Q38042475-81FEFAD4-5D75-440C-9C62-E90BE9310068

Q38042475-8BDFEA45-EE48-421B-B944-255973F2831D

P2888

Q38042475-2D54706C-D0C1-4A15-82F8-9A2A0BF0F721

P304

Q38042475-2F2BA83F-6CA8-4235-8E4A-9EF31E4A5F20

P31

Q38042475-F131BE6F-C715-49DB-823F-AA20F2E6093C

P356

Q38042475-F8582AC2-3701-421A-9AA7-F290A22283E0

P433

Q38042475-99658D37-A2AD-4BFB-B658-8BEAF921DB97

P478

Q38042475-9CE6C1E3-0994-489B-959D-1EE22420E1F2

P50

Q38042475-D590ABC5-A062-4E83-B5D9-DFD4CDA40A6F

P577

Q38042475-921C3A74-C889-47B7-B160-10679BD99B52

P6179

Q38042475-C8536672-B38B-4220-8CFF-632634CE5FDB

P698

Q38042475-03CA91A1-EAC3-4C33-B727-E81A9441BCE3

P356

11633110-000000000-00000

P1433

American Journal of Clinical Dermatology

P1476

Comparative efficacy of biologics in psoriasis: a review

@en

P2093

Cameron E West

http://www.w3.org/2001/XMLSchema#string

Iris H Kim

http://www.w3.org/2001/XMLSchema#string

Jenna L O'Neill

http://www.w3.org/2001/XMLSchema#string

Shawn G Kwatra

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).

Prevalence of joint disease in patients with psoriasis: implications for therapy.

The psychosocial burden of psoriasis.

Problems encountered during anti-tumour necrosis factor therapy.

Heart disease in psoriasis.

P2888

11633110-000000000-00000

P304

365-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11633110-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Steven R. Feldman

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1011699660

http://www.w3.org/2001/XMLSchema#string

P698

22967166

http://www.w3.org/2001/XMLSchema#string